MindMed (OTCQB: MMEDF) CO-CEO Jr Rahn joined Steve Darling from Proactive to announce the company has now added MDMA to its research and development pipeline.
Rahn telling Proactive about some of the clinical studies they are doing including a new one called Project Lucy.
Add related topics to MyProactive
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of MindMed named herein, including the promotion by the Company of MindMed in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HERE